Pepper Hamilton is the sole law firm sponsor of this year’s Association of Bioscience Financial Officers (ABFO) Conference. Held May 29-June 1 in San Francisco, the conference is the premier national event for bioscience financial officers.
David M. Kaplan, chair of the Employee Benefits Practice Group of Pepper Hamilton, will be speaking on the breakout session on "Navigating Your Equity Strategy Through the Biotechnology Company Lifecycle" on Wednesday, May 30 at 1:00-2:30 PM. The interactive session will delve into the latest news to come out of ISS, the SEC and others, as well as what Radford has observed this year in interactions with board, management and proxy advisors. The presenters will discuss corporate guidelines and regulatory development in compensation.
Rachel Bushey, Chair of Life Sciences and Vice Chair of Pepper's Health Sciences Department, will be speaking on the breakout session on "Social Media & Investor Relations: Don't Be Afraid of the Boogeyman" on Thursday, May 31 at 2:45 - 4:15 PM. In the age of instant communication, open discussion forums and “fake news,” how do we properly interact with target audiences in our highly regulated environment? This panel will explore the best (and worst) ways to monitor, engage and disengage with specific audiences (i.e. investors, partners, media, key opinion leaders, patients and others) across social media platforms.
ABFO is a national networking group for biotechnology, med tech and bioscience financial officers. Started in the San Francisco Bay Area in 1988, the organization provides a place to exchange information and ideas, form support networks, and gather for education and friendship. Its 2018 conference will feature speakers from Bank of America Merrill Lynch, Ernst & Young, Russo Partners, and a number of bioscience companies.
San Francisco, CA